As per Intent Market Research, the Percutaneous Transluminal Angioplasty Balloons Catheter Market was valued at USD 2.1 billion in 2024-e and will surpass USD 3.5 billion by 2030; growing at a CAGR of 8.5% during 2025 - 2030.
The Percutaneous Transluminal Angioplasty (PTA) Balloons Catheter market is a significant segment of the medical device industry, focused on the treatment of various artery-related diseases through minimally invasive procedures. PTA is a procedure used to open narrowed or blocked arteries, allowing improved blood flow to critical organs. It is commonly employed in treating coronary artery disease (CAD), peripheral artery disease (PAD), and carotid artery disease (CAD), among other vascular conditions. The balloon catheter is an essential component in this procedure, where a balloon is inflated at the site of blockage to widen the artery.
The PTA balloon catheter market has witnessed steady growth due to the increasing prevalence of cardiovascular diseases and the rising adoption of minimally invasive surgeries. The demand for advanced balloon catheter technologies is also being fueled by the development of drug-eluting balloons and high-pressure balloons, which offer enhanced treatment options with reduced risks of restenosis (re-narrowing of the artery).
Cutting Balloons Segment Dominates the Market
The cutting balloons segment holds the largest market share in the PTA balloon catheter market. Cutting balloons are specialized balloons with small, blade-like elements that are used to incise or cut through resistant plaque during angioplasty. They are particularly effective in treating complex lesions that are difficult to treat with traditional angioplasty balloons.
These balloons allow for precise plaque removal, which helps in improving the expansion of the artery and reduces the chances of restenosis. Cutting balloons are increasingly being used in coronary and peripheral artery procedures, contributing to their dominance in the market.
.JPG)
Coronary Artery Disease (CAD) Segment Leads in Application
Coronary artery disease (CAD) is the largest application segment for PTA balloon catheters. CAD, caused by the buildup of plaque in the coronary arteries, restricts blood flow to the heart and is a leading cause of heart attacks. Percutaneous transluminal angioplasty (PTA) is one of the most common methods for treating CAD, making it a major application area for PTA balloon catheters.
The growing incidence of CAD, driven by lifestyle factors such as poor diet, lack of exercise, and smoking, is fueling the demand for PTA balloon catheters. As the global population ages, the need for advanced and effective treatments for CAD is expected to further increase, driving the growth of the PTA balloon catheter market in the coronary artery disease segment.
Hospitals & Clinics Segment is the Largest End-User
The hospitals and clinics segment is the largest end-user of PTA balloon catheters. These healthcare settings perform a high volume of angioplasty procedures, especially for patients with conditions like coronary artery disease and peripheral artery disease. Hospitals have the infrastructure, skilled medical professionals, and equipment necessary to perform complex procedures, including PTA, making them the primary users of PTA balloon catheters.
The growing adoption of minimally invasive procedures in hospitals and clinics, coupled with the increasing number of patients undergoing angioplasty, further drives the demand for PTA balloon catheters in these settings. Hospitals are expected to continue being the dominant end-users due to their central role in treating cardiovascular diseases.
North America Leads the PTA Balloon Catheter Market
North America is the leading region for the PTA balloon catheter market. The region's dominance is attributed to advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and the presence of leading medical device manufacturers. The United States, in particular, is a major market for PTA balloon catheters, with numerous hospitals and cardiac centers offering advanced treatments for coronary and peripheral artery diseases.
The growing adoption of minimally invasive procedures, along with continuous advancements in PTA balloon catheter technology, further strengthens the market's position in North America. The region's robust regulatory frameworks and high healthcare spending also contribute to the growth of the PTA balloon catheter market.
.JPG)
Competitive Landscape
The PTA balloon catheter market is highly competitive, with several global players involved in the design and manufacturing of advanced balloon catheter products. Companies are focusing on developing innovative balloon catheter technologies, including drug-eluting balloons (DEBs), high-pressure balloons, and cutting balloons, to improve patient outcomes and reduce the risk of restenosis.
Strategic partnerships, mergers, and acquisitions are common in this market as companies look to expand their product portfolios and reach. Furthermore, ongoing research and development efforts are aimed at enhancing the performance and versatility of PTA balloon catheters, ensuring that they meet the growing demand for effective treatments in coronary, peripheral, and carotid artery diseases. The increasing preference for minimally invasive procedures, along with the need for advanced medical devices, will continue to drive competition in the PTA balloon catheter market.
List of Leading Companies:
- Abbott Laboratories
- Boston Scientific
- Medtronic
- Terumo Corporation
- Cordis (Johnson & Johnson)
- B. Braun Melsungen AG
- Cook Medical
- Stryker Corporation
- Penumbra, Inc.
- Asahi Intecc Co., Ltd.
- EndoPhotonix
- AngioDynamics
- Merit Medical Systems, Inc.
- Cardinal Health
- Neovasc Inc.
Recent Developments:
- In December 2024, Abbott Laboratories launched a new high-pressure PTA balloon catheter for coronary artery interventions.
- In November 2024, Boston Scientific received approval for its drug-eluting balloon catheter for peripheral artery disease.
- In October 2024, Medtronic introduced a new cutting balloon catheter for advanced vascular procedures.
- In September 2024, Terumo Corporation partnered with B. Braun Melsungen AG to expand their PTA balloon catheter offerings in the European market.
- In August 2024, Cordis (Johnson & Johnson) launched a new non-drug PTA balloon catheter for carotid artery disease.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 2.1 billion |
|
Forecasted Value (2030) |
USD 3.5 billion |
|
CAGR (2025 – 2030) |
8.5% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Percutaneous Transluminal Angioplasty Balloons Catheter Market By Product Type (Cutting Balloons, High-Pressure Balloons, Drug-Eluting Balloons, Non-Drug Balloons), By Application (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiology Clinics) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
Abbott Laboratories, Boston Scientific, Medtronic, Terumo Corporation, Cordis (Johnson & Johnson), B. Braun Melsungen AG, Cook Medical, Stryker Corporation, Penumbra, Inc., Asahi Intecc Co., Ltd., EndoPhotonix, AngioDynamics, Merit Medical Systems, Inc., Cardinal Health, Neovasc Inc. |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Product Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Cutting Balloons |
|
4.2. High-Pressure Balloons |
|
4.3. Drug-Eluting Balloons |
|
4.4. Non-Drug Balloons |
|
4.5. Others |
|
5. Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Coronary Artery Disease |
|
5.2. Peripheral Artery Disease |
|
5.3. Carotid Artery Disease |
|
5.4. Others |
|
6. Percutaneous Transluminal Angioplasty Balloons Catheter Market, by End-User (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Hospitals & Clinics |
|
6.2. Ambulatory Surgical Centers |
|
6.3. Cardiology Clinics |
|
6.4. Others |
|
7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Regional Overview |
|
7.2. North America |
|
7.2.1. Regional Trends & Growth Drivers |
|
7.2.2. Barriers & Challenges |
|
7.2.3. Opportunities |
|
7.2.4. Factor Impact Analysis |
|
7.2.5. Technology Trends |
|
7.2.6. North America Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Product Type |
|
7.2.7. North America Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Application |
|
7.2.8. North America Percutaneous Transluminal Angioplasty Balloons Catheter Market, by End-User |
|
7.2.9. By Country |
|
7.2.9.1. US |
|
7.2.9.1.1. US Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Product Type |
|
7.2.9.1.2. US Percutaneous Transluminal Angioplasty Balloons Catheter Market, by Application |
|
7.2.9.1.3. US Percutaneous Transluminal Angioplasty Balloons Catheter Market, by End-User |
|
7.2.9.2. Canada |
|
7.2.9.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
7.3. Europe |
|
7.4. Asia-Pacific |
|
7.5. Latin America |
|
7.6. Middle East & Africa |
|
8. Competitive Landscape |
|
8.1. Overview of the Key Players |
|
8.2. Competitive Ecosystem |
|
8.2.1. Level of Fragmentation |
|
8.2.2. Market Consolidation |
|
8.2.3. Product Innovation |
|
8.3. Company Share Analysis |
|
8.4. Company Benchmarking Matrix |
|
8.4.1. Strategic Overview |
|
8.4.2. Product Innovations |
|
8.5. Start-up Ecosystem |
|
8.6. Strategic Competitive Insights/ Customer Imperatives |
|
8.7. ESG Matrix/ Sustainability Matrix |
|
8.8. Manufacturing Network |
|
8.8.1. Locations |
|
8.8.2. Supply Chain and Logistics |
|
8.8.3. Product Flexibility/Customization |
|
8.8.4. Digital Transformation and Connectivity |
|
8.8.5. Environmental and Regulatory Compliance |
|
8.9. Technology Readiness Level Matrix |
|
8.10. Technology Maturity Curve |
|
8.11. Buying Criteria |
|
9. Company Profiles |
|
9.1. Abbott Laboratories |
|
9.1.1. Company Overview |
|
9.1.2. Company Financials |
|
9.1.3. Product/Service Portfolio |
|
9.1.4. Recent Developments |
|
9.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
9.2. Boston Scientific |
|
9.3. Medtronic |
|
9.4. Terumo Corporation |
|
9.5. Cordis (Johnson & Johnson) |
|
9.6. B. Braun Melsungen AG |
|
9.7. Cook Medical |
|
9.8. Stryker Corporation |
|
9.9. Penumbra, Inc. |
|
9.10. Asahi Intecc Co., Ltd. |
|
9.11. EndoPhotonix |
|
9.12. AngioDynamics |
|
9.13. Merit Medical Systems, Inc. |
|
9.14. Cardinal Health |
|
9.15. Neovasc Inc. |
|
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Percutaneous Transluminal Angioplasty Balloons Catheter Market In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Percutaneous Transluminal Angioplasty Balloons Catheter Market The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.jpg)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Percutaneous Transluminal Angioplasty Balloons Catheter Market These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA